Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
In response to some recent successes by several companies operating in the cervical cancer space, we are issuing a two-part special report exploring pre-cervical cancer and CIN.
OneMedRadio interviewed, Andrew Senyei, an MD with an interest in individualized DNA sequencing and gene therapy for heart disease.
Apricus Bio VP Edward Cox discusses the future of drug delivery technology in the rapidly expanding world of personalized medicine.
New York Biotechnology Association (NYBA) will develop its Emerging Companies Showcase at the NYBA 21st Annual Meeting, May 2 in New York City at the Marriott Marquis Hotel.
This week, OneMedPlace is pleased to announce a special interview series exploring current issues facing the diagnostics sector and life sciences with Dr. Shi of […]
In Part III of our interview with Dr. Qin Shi of Edgetech Law we visit the concept of human genome sequencing as a mainstream commodity.
NeuroMetrix is investigating the impact of intensive Diabetes management on Diabetic Peripheral Neuropathy
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
In Part II of our special interview series, Dr. Qin Shi of Edgetech Law discusses the emerging areas of significant unmet need in life science, and what investment opportunities may arise.
Copyright © 2024 | WordPress Theme by MH Themes